121 related articles for article (PubMed ID: 36401481)
1. Ewing sarcoma: what trends in recent works? A holistic analysis with global productivity: A cross-sectional study.
Hassa E; Aliç T
Medicine (Baltimore); 2022 Nov; 101(46):e31406. PubMed ID: 36401481
[TBL] [Abstract][Full Text] [Related]
2. Irinotecan dose schedule for the treatment of Ewing sarcoma.
Slotkin EK; Meyers PA
Pediatr Blood Cancer; 2023 Jan; 70(1):e30005. PubMed ID: 36184748
[TBL] [Abstract][Full Text] [Related]
3. Quality of life and Q-TWiST were not adversely affected in Ewing sarcoma patients treated with combined anlotinib, irinotecan, and vincristine: (Peking University People's Hospital Ewing sarcoma trial-02, PKUPH-EWS-02).
Dong S; Sun K; Xie L; Xu J; Sun X; Ren T; Huang Y; Yang R; Tang X; Yang F; Gu J; Guo W
Medicine (Baltimore); 2021 Dec; 100(51):e28078. PubMed ID: 34941047
[TBL] [Abstract][Full Text] [Related]
4. Irinotecan plus temozolomide in relapsed Ewing sarcoma: an integrated analysis of retrospective studies.
Wang BC; Xiao BY; Lin GH
BMC Cancer; 2022 Mar; 22(1):349. PubMed ID: 35361149
[TBL] [Abstract][Full Text] [Related]
5. Vincristine, irinotecan, and temozolomide treatment for refractory/relapsed pediatric solid tumors: A single center experience.
Büyükkapu Bay S; Kebudi R; Görgün O; Zülfikar B; Darendeliler E; Çakır FB
J Oncol Pharm Pract; 2019 Sep; 25(6):1343-1348. PubMed ID: 30080131
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma.
Koelsche C; Kriegsmann M; Kommoss FKF; Stichel D; Kriegsmann K; Vokuhl C; Grünewald TGP; Romero-Pérez L; Kirchner T; de Alava E; Diaz-Martin J; Hartmann W; Baumhoer D; Antonescu CR; Szuhai K; Flucke U; Dirksen U; Pfister SM; Jones DTW; Mechtersheimer G; von Deimling A
J Cancer Res Clin Oncol; 2019 May; 145(5):1273-1281. PubMed ID: 30895378
[TBL] [Abstract][Full Text] [Related]
7. The clinical heterogeneity of round cell sarcomas with EWSR1/FUS gene fusions: Impact of gene fusion type on clinical features and outcome.
Tsuda Y; Zhang L; Meyers P; Tap WD; Healey JH; Antonescu CR
Genes Chromosomes Cancer; 2020 Sep; 59(9):525-534. PubMed ID: 32362012
[TBL] [Abstract][Full Text] [Related]
8. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
[TBL] [Abstract][Full Text] [Related]
9. Are EWSR1-FLI-positive cell lines from patients with other diagnoses than Ewing sarcoma really Ewing sarcoma cell lines?
Staege MS
Pediatr Blood Cancer; 2019 Aug; 66(8):e27769. PubMed ID: 31006967
[No Abstract] [Full Text] [Related]
10. Molecular assessment of circulating exosomes toward liquid biopsy diagnosis of Ewing sarcoma family of tumors.
Zhang P; Samuel G; Crow J; Godwin AK; Zeng Y
Transl Res; 2018 Nov; 201():136-153. PubMed ID: 30031766
[TBL] [Abstract][Full Text] [Related]
11. Primary Ewing sarcoma of the brain: a case report and literature review.
Kazmi SA; Perry A; Pressey JG; Wellons JC; Hammers Y; Palmer CA
Diagn Mol Pathol; 2007 Jun; 16(2):108-11. PubMed ID: 17525681
[TBL] [Abstract][Full Text] [Related]
12. [Functional genomics of Ewing sarcoma].
Grünewald TGP
Pathologe; 2017 Nov; 38(Suppl 2):198-201. PubMed ID: 28849372
[TBL] [Abstract][Full Text] [Related]
13. Patterns of Translocation Testing in Patients Enrolling in a Cooperative Group Trial for Newly Diagnosed Metastatic Ewing Sarcoma.
DuBois SG; Krailo MD; Buxton A; Lessnick SL; Teot LA; Rakheja D; Crompton BD; Janeway KA; Gorlick RG; Glade-Bender J
Arch Pathol Lab Med; 2021 Dec; 145(12):1564-1568. PubMed ID: 33769463
[TBL] [Abstract][Full Text] [Related]
14. Impact of locus of care on outcomes in adolescents and young adults with osteosarcoma and Ewing sarcoma treated at pediatric versus adult cancer centers: An IMPACT cohort study.
Mortazavi M; Baxter NN; Gupta S; Gupta AA; Lau C; Nagamuthu C; Nathan PC
Pediatr Blood Cancer; 2022 Apr; 69(4):e29458. PubMed ID: 35029312
[TBL] [Abstract][Full Text] [Related]
15. SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma.
Tang SW; Bilke S; Cao L; Murai J; Sousa FG; Yamade M; Rajapakse V; Varma S; Helman LJ; Khan J; Meltzer PS; Pommier Y
Clin Cancer Res; 2015 Sep; 21(18):4184-93. PubMed ID: 25779942
[TBL] [Abstract][Full Text] [Related]
16. The genomic breakpoint and chimeric transcripts in the EWSR1-ETV4/E1AF gene fusion in Ewing sarcoma.
Ishida S; Yoshida K; Kaneko Y; Tanaka Y; Sasaki Y; Urano F; Umezawa A; Hata J; Fujinaga K
Cytogenet Cell Genet; 1998; 82(3-4):278-83. PubMed ID: 9858836
[TBL] [Abstract][Full Text] [Related]
17. Comment on: Irinotecan dose schedule for the treatment of Ewing sarcoma-protracted/metronomic schedule-wording matters!
André N
Pediatr Blood Cancer; 2023 Apr; 70(4):e30124. PubMed ID: 36495251
[No Abstract] [Full Text] [Related]
18. Evaluation of polymorphisms in EWSR1 and risk of Ewing sarcoma: a report from the Childhood Cancer Survivor Study.
DuBois SG; Goldsby R; Segal M; Woo J; Copren K; Kane JP; Pullinger CR; Matthay KK; Witte J; Lessnick SL; Robison LL; Bhatia S; Strong LC
Pediatr Blood Cancer; 2012 Jul; 59(1):52-6. PubMed ID: 21793187
[TBL] [Abstract][Full Text] [Related]
19. Absence of detectable EWS/FLI1 expression after therapy-induced neural differentiation in Ewing sarcoma.
Knezevich SR; Hendson G; Mathers JA; Carpenter B; Lopez-Terrada D; Brown KL; Sorensen PH
Hum Pathol; 1998 Mar; 29(3):289-94. PubMed ID: 9496833
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and molecular spectrum of ewing sarcomas/PNETs, including validation of EWSR1 rearrangement by conventional and array FISH technique in certain cases.
Rekhi B; Vogel U; Basak R; Desai SB; Jambhekar NA
Pathol Oncol Res; 2014 Jul; 20(3):503-16. PubMed ID: 24293381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
